Match!
Alesia Sadosky
Pfizer
Physical therapyPregabalinNeuropathic painFibromyalgiaMedicine
149Publications
32H-index
3,064Citations
What is this?
Publications 149
Newest
#1Kathryn R. Wagner (Johns Hopkins University)H-Index: 36
#2Hoda Abdel-Hamid (University of Pittsburgh)H-Index: 11
Last. Peter I. Karachunski (UMN: University of Minnesota)H-Index: 19
view all 24 authors...
Abstract We report results from a phase 2, randomized, double-blind, 2-period trial (48 weeks each) of domagrozumab and its open-label extension (OLE) in patients with Duchenne muscular dystrophy (DMD). Of 120 ambulatory boys (aged 6 to Clinicaltrials.gov identifiers: NCT02310763 and NCT02907619
Source
#1Shengyuan YuH-Index: 17
#1Sheng-Yuan Yu (Chinese PLA General Hospital)H-Index: 1
Last. Joseph C. CappelleriH-Index: 57
view all 13 authors...
Background Little is known about the patient-reported and economic burdens of postherpetic neuralgia (PHN) among China’s urban population.
2 CitationsSource
#1Fei Yang (Chinese PLA General Hospital)H-Index: 1
#2Shengyuan Yu (Chinese PLA General Hospital)H-Index: 17
Last. Margarita Udall (Pfizer)H-Index: 6
view all 14 authors...
Introduction Few studies have examined the epidemiology of herpes zoster (HZ) and postherpetic neuralgia (PHN) in China. The aim of this study was to estimate the prevalence of HZ and PHN in China, and to examine the clinical characteristics of patients identified with PHN.
1 CitationsSource
#1Ryan S. Paquin (RTP: Research Triangle Park)H-Index: 4
#2Ryan FischerH-Index: 3
Last. Holly L. Peay (RTP: Research Triangle Park)H-Index: 17
view all 14 authors...
Purpose Several gene therapy trials for Duchenne muscular dystrophy initiated in 2018. Trial decision making is complicated by non-curative, time-limited benefits; the progressive, fatal course; and high unmet needs. Here, caregivers and patients prioritize factors influencing decision making regarding participation in early-phase gene therapy trials.
2 CitationsSource
#1Magdolna BarraH-Index: 1
#2Edit RemakH-Index: 2
Last. Alesia SadoskyH-Index: 32
view all 6 authors...
Purpose: The use of parecoxib plus opioids for postoperative analgesia in noncardiac surgical patients seems to be cost-saving in Europe due to a reduction in opioid use and opioid-related adverse events. Given the lack of information on postoperative analgesic use in Asia, this study assessed the economic consequences of the addition of parecoxib to opioids vs opioids alone to treat postsurgical pain in China. Methods: A cost-consequence economic evaluation assessed direct medical costs related...
Source
#1Ian KudelH-Index: 2
#2Markay Hopps (Pfizer)H-Index: 7
Last. Brett R. StaceyH-Index: 32
view all 13 authors...
Background: The aim of this study was to identify the clinical characteristics, treatment usage, and health outcomes of US adults diagnosed with neuropathic pain (NeP) by experienced physicians. Methods: Adults with scores exceeding the threshold for probable NeP (painDETECT ≥19) and diagnosed with NeP by a qualified physician completed a questionnaire that included comorbid conditions, pain symptoms and experiences, medication use, health status (3-level EuroQol 5 Dimensions (EQ-5D-3L]: health ...
3 CitationsSource
#1Margarita Udall (Pfizer)H-Index: 6
#2Ian KudelH-Index: 2
Last. Jb GarciaH-Index: 1
view all 12 authors...
Objectives: Estimate the prevalence of neuropathic pain (NeP) among chronic pain patients attending Brazilian hospitals and pain clinics in Sao Paulo, Ceara, and Bahia and explore clinical characteristics by subtypes: painful diabetic peripheral neuropathy (pDPN), central neuropathic pain (CNP), chronic low back pain with a neuropathic component (CLBP-NeP), postherpetic neuralgia (PHN), post-traumatic neuropathic pain (PTN), and post-surgical neuropathic pain (PSN). Methods: Physicians screened ...
2 CitationsSource
#1Fred N. DavisH-Index: 2
#1Frederick DavisH-Index: 4
Last. Alesia Sadosky (Pfizer)H-Index: 32
view all 6 authors...
Background: While fibromyalgia (FM) is characterized by chronic widespread pain and tenderness, its presentation among patients as a continuum of diseases rather than a single disease contributes to the challenges of diagnosis and treatment. The purpose of this analysis was to distinguish and characterize classes of FM within the continuum using data from chronic pain patients. Methods: FM patients were identified from administrative claims data from the ProCare Systems' network of Michigan pain...
2 CitationsSource
#1Fred N. DavisH-Index: 2
#2Mark GostineH-Index: 3
Last. Alesia Sadosky (Pfizer)H-Index: 32
view all 6 authors...
Objective To evaluate the effectiveness of opioids and/or pregabalin on patient-reported outcomes among fibromyalgia (FM) patients based on levels of improvement. Methods A total of 1,421 FM patients were identified with 3,082 observational periods of opioids with or without pregabalin use between April 2008 and February 2015. Patients were categorized by opioids, and pregabalin with and without opioids; opioids were designated by morphine equivalent dose (MED) of ≤20 (low MED), >20 to <100 (mod...
Source
#1Victoria Bauer (NorthShore University HealthSystem)H-Index: 3
#2Nancy Goodman (NorthShore University HealthSystem)H-Index: 1
Last. Christopher Masi (Emory University)H-Index: 2
view all 11 authors...
PurposeThe purpose of the study was to determine the impact of educational text messages on diabetes self-management activities and outcomes in patients with painful diabetic peripheral neuropathy (pDPN).MethodsPatients with pDPN identified from a large integrated health system who agreed to participate were randomized to 6 months of usual care (UC) or UC plus twice-daily diabetes self-management text messages (UC+TxtM). Outcomes included the Pain Numerical Rating Scale, Summary of Diabetes Self...
4 CitationsSource
12345678910
Close Researchers